drugset / Trial / NCT02358824

CKD-828 (80/5mg) Pharmacokinetic Study

NCT02358824

Phase 1 Completed 48 enrolled Chong Kun Dang Pharmaceutical
RandomizedCrossoverOpen-labelTreatment

Summary

A randomized, open-label, single-dose, four-period, two-way, crossover study,

Timeline

Start
2015-02
Primary completion
2015-05
Completion
2015-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator S-amlodipine Unknown 5 mg Oral
Comparator Telmisartan Other / unclassified 80 mg Oral

Indications